Navigation Links
Regence Worksite Wellness Program Pays Off
Date:9/21/2009

on said.

"These are exciting results," Ganz said. "This demonstrates that Regence's long-term commitment to creating a broad-based, integrated wellness culture is a sound investment."

About Regence

Regence is the largest health insurer in the Northwest / Intermountain Region, offering health, life and dental insurance. Regence serves more than 2.5 million members as Regence BlueShield of Idaho, Regence BlueCross BlueShield of Oregon, Regence BlueCross BlueShield of Utah and Regence BlueShield (selected counties in Washington). Each health plan is a nonprofit independent licensee of the Blue Cross and Blue Shield Association. Regence is committed to improving the health of our members and our communities, and to transforming our health care system. For more information, please visit www.regence.com or follow us on Twitter.


'/>"/>
SOURCE Regence
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Regence Offers InterM to Fill Gap for the Uninsured
2. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
3. Regence Expands MedAdvantage Market, Hits the Road to Educate Seniors
4. Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship
5. Regence Introduces Two New Plans Designed Especially for Small to Mid-Size Companies
6. American Heart Association Honors Regence BlueCross BlueShield of Utah as the States First Start! Fit-Friendly Company
7. American Heart Association Award Recognizes Regence as a Start! Fit-Friendly Company
8. Regence Partners with Multnomah Education Service District to Bring Free Health Services to more than 20,000 Students in Need
9. myRegence.com Wins Three Gold Awards from eHealthcare Strategy & Trends
10. Regence Enables Members to Share Feedback With Each Other When Researching Health Care Provider Options
11. Regence Automates Provider Contracting with Kryptiqs Choreo Contract Manager

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)..., , LONDON, November 21, 2009 /PRNewswire-...est Test Test Test Test Test Test Test Test Test T...est Test Test Test Test Test Test,Test Test Test T... More test More test More test More test More ...test More test More test More test More test More,...
(Date:11/21/2009)... Innovative medical apparel...onference , San Clemente,..., maker of breakthrough medical apparel, today ann...e on display at Medica 2009, a leading internation...seldorf, Germany. Medelita inaugurates its men,s c...
(Date:11/21/2009)... Eric J. Hall, president an...ation of America (AFA) issued the following statem...t detection as part of the new annual wellness for...ction and Affordable Care Act" that was intro...ork, NY (PRWEB) November 21, 2009 -- Eric J. Hall,...
(Date:11/21/2009)... Linwood Group ask whether ...an it be measured? , Lond...reveal that with up to one in three of the adult U...isk of developing alcohol-related liver disease*, ... turning to rehabilitation programmes and resident...
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-First...day that a Special Meeting of Shareholders will be... the Meeting is to consider approval of two specia...approve and authorize the sale of all or substanti...n the terms provided for in the asset purchase agr...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3
...07 The Journal of the American Dental Association...ournals today in publishing a global theme issue o...collaborative effort among the worlds biomedical p...he world of articles on povertys devastating effec...
...wswire/ - IntelliPharmaCeutics Ltd. (the,"Company"... generic drug,commercialization activities. In la...any,s operating,affiliate IntelliPharmaCeutics Cor...plication (known as an ANDA) for a,drug product it...
...ng of Innovative Hypotheses, NEW YORK, Oct. 22 T...e selection of its 6th round of Novel Research,Gra...primed to explore,entirely new ideas on why the lu...oneering innovative lupus research. The outlay of...
...fth largest journal publisher, is proud to be part...uman Development launched today by the Council of ...s to raise awareness and stimulate interest and de... simultaneously publish papers on this topic, enab...
...er 22, 2007) A new study shows that obstacles to ... vary with age. The study presented at CHEST 2007,... of the American College of Chest Physicians (ACCP...e 65 reported cigarette cost and tobacco odor as r...
...Autism in California Lack Proper Healthcare Covera...,Area Chapter of Autism Speaks today announced the...slative Blue Ribbon Commission on,Autism,s recomme... the California State Legislature and Governor,Arn...
Other Medicine News:Health News:Journal of the American Dental Association spotlights poverty 2Health News:IntelliPharmaCeuitics Ltd. Announces Generic Drug Commercialization Activities 2Health News:New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 2Health News:New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 3Health News:New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 4Health News:9 SAGE journals participate in global theme issue on poverty and human development 2Health News:Age affects motivation for quitting smoking 2Health News:San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism 2Health News:San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism 3
(Date:11/20/2009)... , NEW YORK, Nov. 20 Reportlink... is available in its catalogue. ,, Global Mark... http://www.reportlinker.com/p0164742/Global-Mark...m_source=prnewswire&utm_medium=pr&utm_camp...d Reproduction covers the U.S., 15 Countries in Eu...
(Date:11/20/2009)...MINNEAPOLIS, Nov. 20 Bio...lts for its first quarter ended September 30, 2009...ed share, on revenues of $3,263,000. This compare...d share, on revenues of $3,168,000 for the first q... quarter results, Biotel President and CEO Steve S...
(Date:11/20/2009)... FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstCa... BDX ) today announced the completion of its acqui...ased company that develops and manufactures molecu..., In May 2009, BD and HandyLab announced an excl...e molecular assays on the HandyLab Jaguar(TM) plat...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Partnership for Prescription Assistance Prepared to Help Pennsylvania Workers Hurt by Recession 52593 1Partnership for Prescription Assistance Prepared to Help Pennsylvania Workers Hurt by Recession 52593 2Partnership for Prescription Assistance Prepared to Help Pennsylvania Workers Hurt by Recession 52593 3Partnership for Prescription Assistance Prepared to Help Pennsylvania Workers Hurt by Recession 52593 4As the Government Continues to Work Toward Health Care Reform Medtipster is Providing a Free Solution to Rising Health Care Costs for Americans Right 52591 1As the Government Continues to Work Toward Health Care Reform Medtipster is Providing a Free Solution to Rising Health Care Costs for Americans Right 52591 2Human cells secrete cancer killing protein UK study finds 52589 1Human cells secrete cancer killing protein UK study finds 52589 2
...gimen yielded nearly double SVR rate compared to s... protease inhibitor SCH 900518 presented at EASL a...Schering-Plough Corporation (NYSE: SGP ) today r...dy showed boceprevir, its investigational oral hep...eginterferon alfa-2b and ribavirin, significantly ...
...ducation Online Activity and Podcast for Nurses an... lymphoblastic leukemia (ALL) is a complex heterog... in the treatment of pediatric patients, is often ...fessionals who treat adult patients with ALL to ma...e of factors affecting management options for this...
Other Medicine Technology:Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 2Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 3Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 4Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 5Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 6Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 7Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 9Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 10Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 11Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 12Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions 2
Storz Suturing Forceps
Manhattan Eye and Ear Suturing Forceps
Lambert Sleeve Spreader
deJuan Pic Forceps
Medicine Products: